{
    "Trade/Device Name(s)": [
        "EUROIMMUN IFA 40: HEp-20-10"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K131791",
    "Predicate Device Reference 510(k) Number(s)": [
        "K972145"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHN"
    ],
    "Summary Letter Date": "February 26, 2014",
    "Summary Letter Received Date": "January 30, 2014",
    "Submission Date": "January 29, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Anti-nuclear autoantibodies (ANA)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescent microscope (488 nm excitation filter, 510 nm color separator, 520 nm blocking filter, 100 W mercury vapour lamp or LED bluelight)"
    ],
    "Method(s)/Technology(ies)": [
        "Indirect immunofluorescence",
        "BIOCHIP TITERPLANE technique"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Semi-quantitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN IFA 40: HEp-20-10 indirect immunofluorescence assay for detection of ANA in serum to aid diagnosis of systemic rheumatic diseases",
    "Indications for Use Summary": "Indirect immunofluorescence antibody test for qualitative or semi-quantitative detection of antibodies against cell nuclei (ANA) in human serum, used as an aid in the diagnosis of systemic rheumatic diseases with other clinical and laboratory findings",
    "fda_folder": "Immunology"
}